Quantifying stakeholders' preference for implantable medical devices in China: a discrete choice experiment.

IF 2.6 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES International Journal of Technology Assessment in Health Care Pub Date : 2024-01-15 DOI:10.1017/S0266462323002799
Bin Wan, Jiaojie Shen, Jiali Chen, Linjia Weng, Peng Zhao, Yunfei Deng, Lingli Zhang, Feiyi Zhang, Yingpeng Wang, Xin Li, Feng Chang, Haixia Ding, Yun Lu
{"title":"Quantifying stakeholders' preference for implantable medical devices in China: a discrete choice experiment.","authors":"Bin Wan, Jiaojie Shen, Jiali Chen, Linjia Weng, Peng Zhao, Yunfei Deng, Lingli Zhang, Feiyi Zhang, Yingpeng Wang, Xin Li, Feng Chang, Haixia Ding, Yun Lu","doi":"10.1017/S0266462323002799","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>This study aims to gain insight into each attribute as presented in the value of implantable medical devices, quantify attributes' strength and their relative importance, and identify the determinants of stakeholders' preferences.</p><p><strong>Methods: </strong>A mixed-methods design was used to identify attributes and levels reflecting stakeholders' preference toward the value of implantable medical devices. This design combined literature reviewing, expert's consultation, one-on-one interactions with stakeholders, and a pilot testing. Based on the design, six attributes and their levels were settled. Among 144 hypothetical profiles, 30 optimal choice sets were developed, and healthcare professionals (decision-makers, health technology assessment experts, hospital administrators, medical doctors) and patients as stakeholders in China were surveyed. A total of 134 respondents participated in the survey. Results were analyzed by mixed logit model and conditional logit model.</p><p><strong>Results: </strong>The results of the mixed logit model showed that all the six attributes had a significant impact on respondents' choices on implantable medical devices. Respondents were willing to pay the highest for medical devices that provided improvements in clinical safety, followed by increased clinical effectiveness, technology for treating severe diseases, improved implement capacity, and innovative technology (without substitutes).</p><p><strong>Conclusions: </strong>The findings of DCE will improve the current evaluation on the value of implantable medical devices in China and provide decision-makers with the relative importance of the criteria in pricing and reimbursement decision-making of implantable medical devices.</p>","PeriodicalId":14467,"journal":{"name":"International Journal of Technology Assessment in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10859836/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Technology Assessment in Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S0266462323002799","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This study aims to gain insight into each attribute as presented in the value of implantable medical devices, quantify attributes' strength and their relative importance, and identify the determinants of stakeholders' preferences.

Methods: A mixed-methods design was used to identify attributes and levels reflecting stakeholders' preference toward the value of implantable medical devices. This design combined literature reviewing, expert's consultation, one-on-one interactions with stakeholders, and a pilot testing. Based on the design, six attributes and their levels were settled. Among 144 hypothetical profiles, 30 optimal choice sets were developed, and healthcare professionals (decision-makers, health technology assessment experts, hospital administrators, medical doctors) and patients as stakeholders in China were surveyed. A total of 134 respondents participated in the survey. Results were analyzed by mixed logit model and conditional logit model.

Results: The results of the mixed logit model showed that all the six attributes had a significant impact on respondents' choices on implantable medical devices. Respondents were willing to pay the highest for medical devices that provided improvements in clinical safety, followed by increased clinical effectiveness, technology for treating severe diseases, improved implement capacity, and innovative technology (without substitutes).

Conclusions: The findings of DCE will improve the current evaluation on the value of implantable medical devices in China and provide decision-makers with the relative importance of the criteria in pricing and reimbursement decision-making of implantable medical devices.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
量化利益相关者对中国植入式医疗器械的偏好:离散选择实验》。
目的:本研究旨在深入了解植入式医疗器械价值中的各个属性:本研究旨在深入了解植入式医疗器械价值中的各个属性,量化属性的强度及其相对重要性,并确定利益相关者偏好的决定因素:方法:采用混合方法设计来确定反映利益相关者对植入式医疗器械价值偏好的属性和水平。该设计结合了文献查阅、专家咨询、与利益相关者一对一交流以及试点测试。根据这一设计,确定了六个属性及其等级。在 144 个假定特征中,制定了 30 个最优选择集,并对中国的医疗保健专业人员(决策者、卫生技术评估专家、医院管理者、医生)和患者作为利益相关者进行了调查。共有 134 名受访者参与了调查。调查结果通过混合 logit 模型和条件 logit 模型进行分析:混合 logit 模型的结果显示,所有六个属性都对受访者选择植入式医疗器械有显著影响。受访者对提高临床安全性的医疗器械的支付意愿最高,其次是提高临床有效性、治疗严重疾病的技术、提高执行能力和创新技术(无替代品):DCE的研究结果将改善目前中国对植入性医疗器械价值的评估,并为决策者提供植入性医疗器械定价和报销决策中各项标准的相对重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Technology Assessment in Health Care
International Journal of Technology Assessment in Health Care 医学-公共卫生、环境卫生与职业卫生
CiteScore
4.40
自引率
15.60%
发文量
116
审稿时长
6-12 weeks
期刊介绍: International Journal of Technology Assessment in Health Care serves as a forum for the wide range of health policy makers and professionals interested in the economic, social, ethical, medical and public health implications of health technology. It covers the development, evaluation, diffusion and use of health technology, as well as its impact on the organization and management of health care systems and public health. In addition to general essays and research reports, regular columns on technology assessment reports and thematic sections are published.
期刊最新文献
Development of an MCDA Framework for Rare Disease Reimbursement Prioritization in Malaysia. Experiences of patient organizations' involvement in medicine appraisal and reimbursement processes in Finland - a qualitative study. PP78 Real-World Trends And Medical Costs Of Stroke After Transcatheter Aortic Valve Implantation In Korea: A Nationwide, Population-Based Study Can requests for real-world evidence by the French HTA body be planned? An exhaustive retrospective case-control study of medicinal products appraisals from 2016 to 2021. A systematic review of the cost and cost-effectiveness of immunoglobulin treatment in patients with hematological malignancies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1